TrialJournal of psychopharmacology (Oxford, England)2022

A randomized controlled trial of 3,4-methylenedioxymethamphetamine (MDMA) and fear extinction retention in healthy adults.

Jessica L Maples-Keller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.